Search by Drug Name or NDC
NDC 00024-5860-01 Clolar 1 mg/mL Details
Clolar 1 mg/mL
Clolar is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sanofi-Aventis U.S. LLC. The primary component is CLOFARABINE.
MedlinePlus Drug Summary
Clofarabine is used to treat acute lymphoblastic leukemia (ALL; a type of cancer of the white blood cells) in children and young adults 1 to 21 years old who have already received at least two other treatments. Clofarabine is in a class of medications called purine nucleoside antimetabolites. It works by killing existing cancer cells and limiting the development of new cancer cells.
Related Packages: 00024-5860-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Clofarabine Injection
Product Information
NDC | 00024-5860 |
---|---|
Product ID | 0024-5860_06aeff93-91f9-4ce6-ac41-173d56e34b1d |
Associated GPIs | 21300008002020 |
GCN Sequence Number | 058571 |
GCN Sequence Number Description | clofarabine VIAL 20 MG/20ML INTRAVEN |
HIC3 | V1B |
HIC3 Description | ANTINEOPLASTIC - ANTIMETABOLITES |
GCN | 24037 |
HICL Sequence Number | 026816 |
HICL Sequence Number Description | CLOFARABINE |
Brand/Generic | Brand |
Proprietary Name | Clolar |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | clofarabine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION |
Route | INTRAVENOUS |
Active Ingredient Strength | 1 |
Active Ingredient Units | mg/mL |
Substance Name | CLOFARABINE |
Labeler Name | Sanofi-Aventis U.S. LLC |
Pharmaceutical Class | Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021673 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00024-5860-01 (00024586001)
NDC Package Code | 0024-5860-01 |
---|---|
Billing NDC | 00024586001 |
Package | 1 VIAL, SINGLE-USE in 1 BOX (0024-5860-01) / 20 mL in 1 VIAL, SINGLE-USE |
Marketing Start Date | 2013-04-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |